Angioplasty Balloons Market Research, 2033
The global angioplasty balloons market size was valued at $2.6 billion in 2023, and is projected to reach $3.6 billion by 2033, growing at a CAGR of 3.4% from 2024 to 2033. The global Angioplasty balloons market has experienced growth due to several factors such as increasing prevalence of cardiovascular diseases and advancements in balloon catheter technologies. Key factors include the rising aging population, lifestyle-related health issues, and a growing preference for minimally invasive procedures. In addition, innovations like drug-eluting balloons and improved catheter designs are enhancing market growth.
Market Introduction and Definition
Angioplasty, often referred to as percutaneous transluminal coronary angioplasty (PTCA) , is a minimally invasive procedure utilized to open narrowed or blocked blood vessels that supply blood to the heart. The primary tool used in this procedure is the angioplasty balloon, a small balloon attached to a catheter. During angioplasty, a cardiologist inserts the catheter, typically through an artery in the groin or wrist, and guides it to the site of the blockage in the coronary artery. Once in position, the balloon is carefully inflated. This inflation compresses the plaque against the artery walls, effectively widening the vessel and restoring proper blood flow to the heart muscle. After the artery is sufficiently widened, the balloon is deflated and removed. Sometimes, a stent is placed at the site to keep the artery open. Angioplasty with balloon dilation has become a common and effective treatment for coronary artery disease, significantly reducing symptoms such as chest pain and improving the quality of life for patients with heart conditions.
Key Takeaways
- The angioplasty balloons industry study covers 20 countries. The research includes a segment analysis of each country in terms of value ($Million) for the projected period 2023-2033.
- More than 1, 500 product literatures, industry releases, annual reports, and other such documents of major angioplasty balloons industry participants along with authentic industry journals, trade associations' releases, and government websites have been reviewed for generating high-value industry insights.
- The study integrated high-quality data, professional opinions and analysis, and critical independent perspectives. The research approach is intended to provide a balanced view of global markets and to assist stakeholders in making educated decisions to achieve their most ambitious growth objectives.
Key Market Dynamics
The angioplasty balloons market size is driven by several key factors that underscore its growth and significance in cardiovascular care. One of the primary drivers is the increasing prevalence of cardiovascular diseases globally, fueled by aging populations and unhealthy lifestyles. This demographic shift has led to a rising demand for effective treatments like angioplasty, which offers minimally invasive options for restoring blood flow in blocked arteries. Advancements in balloon catheter technologies, such as the development of drug-eluting balloons that release medication to prevent reblockage, have further enhanced the efficacy and safety of these procedures. For instance, companies like Medtronic and Abbott have introduced innovative balloon catheters that improve procedural outcomes and patient recovery times.
However, the angioplasty balloons market growth faces several challenges that act as restraints. The high cost associated with these procedures and devices can limit accessibility, particularly in developing regions where healthcare resources are scarce. Stringent regulatory requirements also pose barriers to market entry and product approval, adding complexity and time to the development and commercialization process. Moreover, despite technological advancements, there remains a risk of complications associated with angioplasty, such as arterial dissection or restenosis, which require careful patient selection and monitoring.
The market presents significant angioplasty balloons market opportunity for growth and innovation. The ongoing development of next-generation balloons, including biodegradable and bioresorbable materials, holds promise for reducing long-term risks and improving patient outcomes. Expansion into emerging markets, where healthcare infrastructure is rapidly developing, presents new avenues for market penetration and growth. Additionally, increasing investment in healthcare infrastructure and the growing focus on personalized medicine are creating opportunities for collaborations and partnerships aimed at advancing angioplasty technologies. Moreover, the adoption of telemedicine and remote monitoring solutions is poised to enhance patient care and follow-up, potentially expanding the reach of angioplasty procedures to underserved populations globally. Overall, the growth during angioplasty balloons market forecast is poised for continued expansion driven by innovation, demographics, and evolving healthcare needs.
Market Segmentation
The angioplasty balloons market is segmented into type, application, end user, and region. On the basis of type, the market is classified into normal balloons, drug eluting balloons, cutting balloons, and scoring balloons. By application, the market is bifurcated into peripheral and coronary. By end user, the market is divided into ASCs, hospitals, and Cath labs. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Regional/Country Market Outlook
The highest angioplasty balloons market share in North America is driven by several key factors that highlight its robust growth trajectory within the region. One of the primary drivers is the high prevalence of cardiovascular diseases, including coronary artery disease, which remains a leading cause of mortality in the U.S. and Canada. This demographic reality has led to a consistent demand for advanced cardiovascular interventions like angioplasty, which effectively alleviate symptoms and improve patient outcomes. For instance, in 2020, the American Heart Association reports that approximately 18.2 million adults in the U.S. alone are affected by coronary artery disease, underscoring the substantial patient pool requiring intervention.
Advancements in balloon catheter technologies further propel market expansion in North America. Innovations such as drug-eluting balloons, which administer medication directly to the treated artery to prevent restenosis, have significantly enhanced procedural success rates and patient recovery times. Companies like Boston Scientific and Medtronic continue to innovate in this space, introducing new catheter designs and materials that improve flexibility, deliverability, and patient safety during angioplasty procedures.
- In September 2023, the UK was awarded the Innovative Cardiovascular Health Program to improve heart health in Kentucky.
- In February 2024, UC Davis Health launched an at-home care program transforming post-angioplasty care.
Industry Trends
- In December 2022, Dr. Hans Henri P. Kluge, the Regional Director of WHO for Europe, introduced a new Signature Initiative that will be especially relevant to the nations in the Region with the highest rates of CVDs, the highest prevalence of hypertension, inadequate control of hypertension, and high salt consumption.
- Million Hearts 2022 is a national initiative co-led by CDC and the Centers for Medicare & Medicaid Services to prevent 1 million heart attacks and strokes in 5 years. The initiative focuses partner actions on a small set of priorities selected for their impact on heart disease, stroke, and related conditions.
Patent Analysis, By Country, 2015-2024
U.S. witnessed the highest number of patent approvals and applications, due to favorable government policies, new technological advancement and new product launches in the country. European Patent Office has 10.0% of the total number of patents, followed by PCT at 9.7% and Canada at 5.7%.
Competitive Landscape
The major angioplasty balloons market share players operating in the angioplasty balloons market include Abbott Laboratories, B. Braun Melsungen AG, BIOTRONIK SE & Co. KG, Boston Scientific Corporation, C. R. Bard, Inc., Cardinal Health, Inc., Medtronic plc., MicroPort Scientific Corporation, Terumo Corporation, and THE SPECTRANETICS CORPORATION. Other players in angioplasty balloons market includes Lepu Medical Technology (Beijing) Co., Ltd., Meril Life Sciences Pvt. Ltd., and COOK MEDICAL INC. and so on.
Recent Key Strategies and Developments
- In January 2022, Cardiovascular Systems Inc. and OrbusNeich Medical Company Ltd. announced that the U.S. Food and Drug Administration (FDA) had provided approval to the Scoreflex NC, a focused force Percutaneous Transluminal Coronary Angioplasty (PTCA) scoring balloon consisting of a dual-wire system, which facilitates controlled plaque modification at low pressure.
- ?In February 2023, SIS Medical AG launched the OPN NC PTCA dilatation catheter in the U.S. The devices, which uses the TWIN-Wall technology, has been approved by the FDA and provides high-pressure resistance of up to 35atm.
- In November 2022, Johnson & Johnson announced a definitive agreement for the acquisition of Abiomed, a leader in heart support and recovery technologies, with an upfront payment of $380 per share, which equates to $16.6 billion. With this acquisition, Johnson & Johnson aims to develop breakthrough treatments for cardiovascular diseases and reach more patients globally.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the angioplasty balloons market analysis from 2024 to 2033 to identify the prevailing angioplasty balloons market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the angioplasty balloons market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global angioplasty balloons market trends, key players, market segments, application areas, and market growth strategies.
Key Sources Referred
- Centers for Disease Control and Prevention
- World Health Organization
- National Center for Biotechnology Information
- The Lancet
- National Perinatal Epidemiology and Statistics Unit (NPESU)
- Science Direct
- Health Resources and Services Administration (HRSA)
- Department of Health and Human Services (HHS)
- National Institutes of Health (NIH)
Angioplasty Balloons Market Report Highlights
| Aspects | Details |
 Market Size By 2033 | USD 3.6 Billion |
 Growth Rate | CAGR of 3.4% |
 Forecast period | 2024 - 2033 |
 Report Pages | 260 |
 By Type |
|
 By Application |
|
 By End User |
|
 By Region |
|
 Key Market Players | B. Braun Melsungen AG, MicroPort Scientific Corporation, Terumo Corporation, C. R. Bard, Inc., Abbott Laboratories, Biotronik SE & Co. KG, MEDTRONIC PLC., Cardinal Health, Inc, Boston Scientific Corporation, THE SPECTRANETICS CORPORATION |
The growth of the angioplasty balloons market is driven by the increasing prevalence of cardiovascular diseases, advancements in balloon technologies, and the rising demand for minimally invasive procedures.
Angioplasty balloons are medical devices used to open narrowed or blocked blood vessels, typically arteries, by inflating the balloon at the site of the obstruction to restore proper blood flow.
The Abbott Laboratories, B. Braun Melsungen AG, BIOTRONIK SE & Co. KG, Boston Scientific Corporation, C. R. Bard, Inc., Cardinal Health, Inc., Medtronic plc., MicroPort Scientific Corporation, Terumo Corporation held a high market position in 2023.
The base year is 2023 in angioplasty balloons market.
The forecast period for angioplasty balloons market is 2024 to 2033.
The market value of angioplasty balloons market in 2033 is $3.6 billion.
The total market value of angioplasty balloons market is $2.6 billion in 2023.
Loading Table Of Content...
